Related Experiment Video

Updated: Jan 26, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

33.8K

Tempol treatment shows phenotype improvement in mdx mice

Túlio de Almeida Hermes1, Rafael Dias Mâncio1, Aline Barbosa Macedo1

  • 1Department of Structural and Functional Biology, Institute of Biology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.

Plos One
|April 23, 2019
PubMed

Insights

Tempol treatment improved muscle strength and reduced degeneration in mdx mice, offering a potential therapeutic strategy for Duchenne muscular dystrophy (DMD). This study investigated Tempol

Area of Science:

  • Biomedical Science
  • Muscle Biology
  • Pharmacology

Background:

  • Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration.
  • Current treatments for DMD have limitations, necessitating the exploration of novel therapeutic strategies.
  • The potential therapeutic effects of Tempol on dystrophic muscle phenotypes remain largely uninvestigated.

Purpose of the Study:

  • To evaluate the effects of Tempol on muscle degeneration, inflammatory processes, and angiogenesis in mdx mice, a model for DMD.
  • To assess Tempol's impact on muscle strength and overall dystrophic phenotype.

Main Methods:

  • Mdx mice were assigned to three groups: saline control (mdxS), prednisolone control (mdxP), and Tempol-treated (mdxT).
  • Tempol was administered via intraperitoneal injections (100 mg/kg).
  • Muscle strength, myonecrosis, inflammatory response, and angiogenesis were assessed in diaphragm (DIA) and biceps brachii (BB) muscles.

Main Results:

  • Tempol treatment significantly improved muscle strength in mdx mice.
  • Tempol administration reduced myonecrosis and the inflammatory response in dystrophic DIA and BB muscles.
  • No beneficial effects of Tempol on angiogenesis were observed in the studied muscles.

Conclusions:

  • Tempol treatment demonstrates a beneficial effect on the dystrophic phenotype in mdx mice.
  • These findings support Tempol as a potential therapeutic agent for Duchenne muscular dystrophy.
  • Further research is warranted to explore Tempol's mechanisms and long-term efficacy in DMD.

More Related Videos

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.4K
Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer09:52

Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer

Published on: April 26, 2018

13.1K

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K
Improving Translational Accuracy02:07

Improving Translational Accuracy

3.6K
Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
7.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
850
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
973